Letrozol Lambda 2,5 mg filmomhulde tabletten Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

letrozol lambda 2,5 mg filmomhulde tabletten

lambda therapeutics limited - letrozol - filmomhulde tablet - cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; lactose 1-water ; macrogol 400 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; ijzeroxide geel (e 172) ; lactose 1-water ; macrogol 400 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat (e468) ; siliciumdioxide (e 551) ; talk (e 553 b) ; titaandioxide (e 171), - letrozole

Victrelis Europese Unie - Nederlands - EMA (European Medicines Agency)

victrelis

merck sharp dohme ltd - boceprevir - hepatitis c, chronisch - antivirale middelen voor systemisch gebruik - victrelis is geïndiceerd voor de behandeling van chronische hepatitis-c (chc) genotype 1 infectie, in combinatie met peginterferon alfa en ribavirine, bij volwassen patiënten met gecompenseerd leverziekte die eerder onbehandeld of die hebben gefaald vorige therapie.

Tremfya Europese Unie - Nederlands - EMA (European Medicines Agency)

tremfya

janssen-cilag international nv - guselkumab - psoriasis - immunosuppressiva - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.

Quetiapine Bluefish 200 mg tabletten met verlengde afgifte Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

quetiapine bluefish 200 mg tabletten met verlengde afgifte

bluefish pharmaceuticals ab - quetiapinefumaraat samenstelling overeenkomend met; quetiapine; - tablet met verlengde afgifte - quetiapine

Quetiapine Bluefish 300 mg tabletten met verlengde afgifte Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

quetiapine bluefish 300 mg tabletten met verlengde afgifte

bluefish pharmaceuticals ab - quetiapinefumaraat samenstelling overeenkomend met; quetiapine; - tablet met verlengde afgifte - quetiapine

Quetiapine Bluefish 400 mg tabletten met verlengde afgifte Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

quetiapine bluefish 400 mg tabletten met verlengde afgifte

bluefish pharmaceuticals ab - quetiapinefumaraat samenstelling overeenkomend met; quetiapine; - tablet met verlengde afgifte - quetiapine

Veklury Europese Unie - Nederlands - EMA (European Medicines Agency)

veklury

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Regkirona Europese Unie - Nederlands - EMA (European Medicines Agency)

regkirona

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immuun-sera en immunoglobulinen, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Xevudy Europese Unie - Nederlands - EMA (European Medicines Agency)

xevudy

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immuun-sera en immunoglobulinen, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Evusheld Europese Unie - Nederlands - EMA (European Medicines Agency)

evusheld

astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.